MICHAEL ZABOSKI: Open Payments
NPI 1043302946 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,972 in 168 payments from 25 companies in 2025. Trend: 2023 $3,019 · 2024 $3,057 · 2025 $2,972
Food & beverage: $2,961Education: $11
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $335 |
| GlaxoSmithKline, LLC. | 17 | $306 |
| Corcept Therapeutics | 18 | $294 |
| Novo Nordisk Inc | 17 | $281 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $203 |
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| PFIZER INC. | 9 | $156 |
| Lilly USA, LLC | 9 | $146 |
| Ceribell, Inc. | 1 | $145 |
| Lundbeck LLC | 8 | $136 |
Products named: Korlym, VRAYLAR, Kerendia, BREZTRI, TRELEGY ELLIPTA, POCKET EEG DEVICE, JARDIANCE, VYEPTI.
Industry payments across NJ — which companies pay providers there.
